High Follicle-Stimulating Hormone Level Associated With Risk of Rheumatoid Arthritis and Disease Activity

Overview

Journal Front Endocrinol (Lausanne)

Specialty Endocrinology

Date 2022 May 9

PMID 35527996

Authors

Xianhui Zhang

Pengyan Qiao

Qianyu Guo

Zixie Liang

Jie Pan

Fengping Wu

Xuexue Wang

Liyun Zhang

Affiliations

Soon will be listed here.

Abstract

Background: The prevalence of rheumatoid arthritis (RA) has significant gender and age difference. The peak age of RA is consistent with the age of menopause, which is accompanied by a sharp increase in serum follicle-stimulating hormone (FSH) level. This study aims to identify the FSH levels in female RA patients and the relationship with diseases activity.

Methods: In total, 79 female RA patients and 50 age-matched controls were included in our study. Serum sex hormones levels were measured using chemiluminescence. RA patients were grouped by FSH quartile. Disease activity and inflammatory marks were analyzed among groups.

Results: Lower sex hormones and higher gonadotropin were found in RA patients. Serum FSH level was significantly higher in RA patients than in the age-match controls (57.58 ± 15.94 vs. 43.11 ± 19.46, p=0.025). Even after adjusting for age (OR: 1.071; 95%CI: 1.006-1.139; p = 0.031), luteinizing hormone (LH), estradiol (E), and testosterone (T) OR: 1.066; 95%CI: 1.003-1.133; p = 0.039), the OR were still more than one. RA patients in the higher quartiles had higher ESR, DAS28-ESR and DAS28-CRP (p<0.05) than the lowest quartile. Besides, menopause age was significantly related with onset age in post-menopause RA patients (r = 0.432, p =0.008).

Conclusion: High FSH appears to be a risk factor for RA and is positively associated with their disease activity. Early menopause might be an essential factor of RA.

Citing Articles

Helper T cells: A potential target for sex hormones to ameliorate rheumatoid arthritis? (Review).

Niu Q, Hao J, Li Z, Zhang H Mol Med Rep. 2024; 30(6).

PMID: 39370806 PMC: 11450432. DOI: 10.3892/mmr.2024.13339.

The Loss of Estradiol by Androgen Deprivation in Prostate Cancer Patients Shows the Importance of Estrogens in Males.

Coelingh Bennink H, Prowse A, Egberts J, Debruyne F, Huhtaniemi I, Tombal B J Endocr Soc. 2024; 8(7):bvae107.

PMID: 38883397 PMC: 11177789. DOI: 10.1210/jendso/bvae107.

Epidemiology and Risk Factors for Rheumatoid Arthritis Development.

Venetsanopoulou A, Alamanos Y, Voulgari P, Drosos A Mediterr J Rheumatol. 2024; 34(4):404-413.

PMID: 38282942 PMC: 10815538. DOI: 10.31138/mjr.301223.eaf.

Review of mendelian randomization studies on age at natural menopause.

Zhang X, Huangfu Z, Wang S Front Endocrinol (Lausanne). 2023; 14:1234324.

PMID: 37766689 PMC: 10520463. DOI: 10.3389/fendo.2023.1234324.

Role of Estrogen Receptor α in Aging and Chronic Disease.

Isola J, Ko S, Ocanas S, Stout M Adv Geriatr Med Res. 2023; 5(2).

PMID: 37425648 PMC: 10327608. DOI: 10.20900/agmr20230005.

References

Qi S, Xin R, Guo W, Liu Y . Meta-analysis of oral contraceptives and rheumatoid arthritis risk in women. Ther Clin Risk Manag. 2014; 10:915-23. PMC: 4226450. DOI: 10.2147/TCRM.S70867. View

Pikwer M, Bergstrom U, Nilsson J, Jacobsson L, Turesson C . Early menopause is an independent predictor of rheumatoid arthritis. Ann Rheum Dis. 2011; 71(3):378-81. DOI: 10.1136/ard.2011.200059. View

Pikwer M, Giwercman A, Bergstrom U, Nilsson J, Jacobsson L, Turesson C . Association between testosterone levels and risk of future rheumatoid arthritis in men: a population-based case-control study. Ann Rheum Dis. 2013; 73(3):573-9. DOI: 10.1136/annrheumdis-2012-202781. View

Wadstrom H, Pettersson A, Smedby K, Askling J . Risk of breast cancer before and after rheumatoid arthritis, and the impact of hormonal factors. Ann Rheum Dis. 2020; 79(5):581-586. PMC: 7213316. DOI: 10.1136/annrheumdis-2019-216756. View

Baillargeon J, Al Snih S, Raji M, Urban R, Sharma G, Sheffield-Moore M . Hypogonadism and the risk of rheumatic autoimmune disease. Clin Rheumatol. 2016; 35(12):2983-2987. PMC: 5544431. DOI: 10.1007/s10067-016-3330-x. View

Zhang X, Zhang Y, Chen X, Qiao P, Zhang L . Assessment of the Ovarian Reserve by Serum Anti-Müllerian Hormone in Rheumatoid Arthritis Patients: A Systematic Review and Meta-Analysis. Int Arch Allergy Immunol. 2021; 183(4):462-469. DOI: 10.1159/000520133. View

Doran M, Pond G, Crowson C, OFallon W, Gabriel S . Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty-year period. Arthritis Rheum. 2002; 46(3):625-31. DOI: 10.1002/art.509. View

Abu-Taha M, Rius C, Hermenegildo C, Noguera I, Cerda-Nicolas J, Issekutz A . Menopause and ovariectomy cause a low grade of systemic inflammation that may be prevented by chronic treatment with low doses of estrogen or losartan. J Immunol. 2009; 183(2):1393-402. DOI: 10.4049/jimmunol.0803157. View

Kass A, Lea T, Torjesen P, Gulseth H, Forre O . The association of luteinizing hormone and follicle-stimulating hormone with cytokines and markers of disease activity in rheumatoid arthritis: a case-control study. Scand J Rheumatol. 2010; 39(2):109-17. DOI: 10.3109/03009740903270607. View

10.

Straub R . The complex role of estrogens in inflammation. Endocr Rev. 2007; 28(5):521-74. DOI: 10.1210/er.2007-0001. View

11.

Doran M, Crowson C, OFallon W, Gabriel S . The effect of oral contraceptives and estrogen replacement therapy on the risk of rheumatoid arthritis: a population based study. J Rheumatol. 2004; 31(2):207-13. View

12.

Ji Y, Liu P, Yuen T, Haider S, He J, Romero R . Epitope-specific monoclonal antibodies to FSHβ increase bone mass. Proc Natl Acad Sci U S A. 2018; 115(9):2192-2197. PMC: 5834707. DOI: 10.1073/pnas.1718144115. View

13.

Yang D, Krasnova A, Nead K, Choueiri T, Hu J, Hoffman K . Androgen deprivation therapy and risk of rheumatoid arthritis in patients with localized prostate cancer. Ann Oncol. 2017; 29(2):386-391. DOI: 10.1093/annonc/mdx744. View

14.

Islander U, Jochems C, Lagerquist M, Forsblad-dElia H, Carlsten H . Estrogens in rheumatoid arthritis; the immune system and bone. Mol Cell Endocrinol. 2010; 335(1):14-29. DOI: 10.1016/j.mce.2010.05.018. View

15.

Spector T, Brennan P, Harris P, Studd J, Silman A . Does estrogen replacement therapy protect against rheumatoid arthritis?. J Rheumatol. 1991; 18(10):1473-6. View

16.

Xiong J, Kang S, Wang Z, Liu X, Kuo T, Korkmaz F . FSH blockade improves cognition in mice with Alzheimer's disease. Nature. 2022; 603(7901):470-476. PMC: 9940301. DOI: 10.1038/s41586-022-04463-0. View

17.

Taneja C, Gera S, Kim S, Iqbal J, Yuen T, Zaidi M . FSH-metabolic circuitry and menopause. J Mol Endocrinol. 2019; 63(3):R73-R80. PMC: 6992500. DOI: 10.1530/JME-19-0152. View

18.

Li Q, Zheng D, Lin H, Zhong F, Liu J, Wu Y . High Circulating Follicle-Stimulating Hormone Level Is a Potential Risk Factor for Renal Dysfunction in Post-Menopausal Women. Front Endocrinol (Lausanne). 2021; 12:627903. PMC: 8047631. DOI: 10.3389/fendo.2021.627903. View

19.

Iqbal J, Sun L, Kumar T, Blair H, Zaidi M . Follicle-stimulating hormone stimulates TNF production from immune cells to enhance osteoblast and osteoclast formation. Proc Natl Acad Sci U S A. 2006; 103(40):14925-30. PMC: 1595452. DOI: 10.1073/pnas.0606805103. View

20.

Weitzmann M, Pacifici R . Estrogen deficiency and bone loss: an inflammatory tale. J Clin Invest. 2006; 116(5):1186-94. PMC: 1451218. DOI: 10.1172/JCI28550. View